Malignant Adrenal Gland Neoplasm — Trials

Malignant Adrenal Gland Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

99 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 16
Ph III recruiting: 0
Growth YoY: —
Industry share: 4%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00924989	A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma(GALACCTIC)	completed	Phase 3	139	Astellas Pharma IncINDUSTRY	9	Nov 20, 2024	clinicaltrials
NCT03723941	Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma(ACACIA)	completed	Phase 3	40	Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER